Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA Appoints David Apple to Board of Directors
…for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with pharmaceutical and biotechnology partners and patients to accelerate scientific breakthroughs. The CMTA also offers…
Evolution: CMTA Board Welcomes Coulie & Marks
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments and a cure to patients, is pleased to announce the appointment of Bernard…
Sign Up for CMTA eNews
Thank you for your interest in signing up for CMTA E-News. We look forward to keeping you informed about CMTA research, events, fundraising and more! By submitting this form, you…
Understanding CMT4J: A Natural History Study
The purpose of this study is to observe and understand the progression of CMT4J over time. By tracking the natural course of the disease, researchers aim to discover how CMT4J…
CMTA Announces Participation in Seed Extension Round for Armatus Bio for Novel CMT1A Gene Therapy
…went on to say that “the venture philanthropy arm will work in tandem with STAR (Strategy to Accelerate Research), the arm of CMTA which is the largest private funder of…
CMTA Awards $225,483 for Study On Using ASOs to Treat CMT2E
…is the largest philanthropic funder of CMT research worldwide. The CMTA’s Strategy to Accelerate Research (STAR) brings the best CMT researchers, clinicians, and experts in therapy development together with patients,…
Medications and Charcot-Marie-Tooth Disease
There currently are no available treatments that act to slow the progression of Charcot-Marie-Tooth disease. There are promising CMT research studies that indicate that this may change in the near…
CMTA Updates List of Neurotoxic Meds Potentially More Hazardous to CMT Patients
…their families. The CMTA has invested $23.5 million in the search for a cure and its Strategy to Accelerate Research (STAR) brings world-renowned CMT researchers together with pharmaceutical and biotechnology…
The CMT&ME Study: What It’s Like to Live with CMT
There’s been little research to date into how CMT affects the lives of patients. The French company Pharnext, CMT scientific experts, and international patient advocacy organizations (PAOs) have therefore partnered…
The Fall 2020 CMTA Report
…issue is available now and full of information for you. Inside, we bring you coverage of CMT research projects with a special focus on CMT1A, stories and perspectives from people…